Company Filing History:
Years Active: 2009-2011
Title: The Innovative Contributions of Ok-kyoung Son
Introduction
Ok-kyoung Son is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in cancer diagnostics. With a total of 4 patents, his work has the potential to impact the lives of many individuals affected by cancer.
Latest Patents
Ok-kyoung Son's latest patents include groundbreaking innovations in the diagnosis of colon and breast cancer. One of his patents focuses on a polynucleotide associated with colon cancer, which comprises a single nucleotide polymorphism, a microarray, and a diagnostic kit. This invention provides a polynucleotide that includes at least 10 contiguous nucleotides of a specific nucleotide sequence, facilitating the diagnosis of colon cancer. Another significant patent addresses breast cancer, offering a polynucleotide for diagnosis or treatment that also includes at least 10 contiguous nucleotides from a defined sequence. These advancements represent a crucial step forward in cancer diagnostics.
Career Highlights
Ok-kyoung Son is currently employed at Samsung Electronics Co., Ltd., where he continues to innovate and develop new technologies. His work at this leading technology company allows him to collaborate with other experts in the field and contribute to significant advancements in healthcare technology.
Collaborations
Some of Ok-kyoung Son's notable coworkers include Yeon-Su Lee and Kyung-hee Park, who contribute to the collaborative environment that fosters innovation and research excellence.
Conclusion
In summary, Ok-kyoung Son's contributions to cancer diagnostics through his patents and work at Samsung Electronics Co., Ltd. highlight his role as a key innovator in the field. His research has the potential to improve diagnostic methods and ultimately enhance patient care.